Question 1

What is Camurus?

Accepted Answer

Camurus is a Company.

Question 2

How often does Camurus appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 16 articles.

Question 3

When was Camurus first tracked by Ergen?

Accepted Answer

First tracked on Jun 01, 2026.

Question 4

When was Camurus last mentioned in news?

Accepted Answer

Last active on Jul 21, 2026.

Question 5

What is Camurus's current news sentiment?

Accepted Answer

Aggregate sentiment score: 65 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Camurus in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Camurus?

Accepted Answer

FDA accepts Camurus NDA resubmission for CAM2029 (Jul 17, 2026, 6 articles).

Question 8

How did the "FDA accepts Camurus NDA resubmission for CAM2029" event impact Camurus?

Accepted Answer

Camurus is the sponsor of the NDA; acceptance for review is a positive step toward US approval, which would expand its market for CAM2029.

Question 9

How did the "Eli Lilly Expands Camurus Collaboration" event impact Camurus?

Accepted Answer

Camurus will receive an initial payment of $5 million and is eligible for up to $290 million in development and regulatory milestone payments, $580 million in sales-based milestone payments, and tiered mid-single-digit royalties on product sales, validating its Fluid Crystal technology and boosting its financial outlook.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.